# Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-monlunabant-in-adults-with-obesity-and-metabolic-syndrome/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Filip K. Knop,George Kunos,Dror Dicker,Jean‐Sébastien Paquette,Louis J. Aronne,Ofir Frenkel,Thomas Holst‐Hansen,Karine Lalonde,Jisoo Lee,Glenn Crater |
| Citations | 10 |
| DOI | 10.1016/s2213-8587(25)00216-5 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | green |
| OA URL | https://pmc.ncbi.nlm.nih.gov/articles/PMC12969592/ |
| OpenAlex ID | https://openalex.org/W4414708467 |
| PMID | 41038215 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Thomas Holst‐Hansen](https://scholariq.org/researchers/thomas-holst-hansen/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Cannabis and Cannabinoid Research](https://scholariq.org/topics/cannabis-and-cannabinoid-research/)

## Paper topics

- [Cannabis and Cannabinoid Research](https://scholariq.org/topics/cannabis-and-cannabinoid-research/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)
- [Forensic Toxicology and Drug Analysis](https://scholariq.org/topics/forensic-toxicology-and-drug-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.